{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:17:47Z","timestamp":1792318667888,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.berh.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:56:55Z","timestamp":1536886615000},"page":"223-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis"],"prefix":"10.1016","volume":"32","author":[{"given":"Francesca","family":"Ingegnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.berh.2018.08.005_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.berh.2010.10.007","article-title":"Epidemiology of systemic sclerosis","volume":"24","author":"Nikpour","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib3","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10067-013-2460-7","article-title":"Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis","volume":"33","author":"Baron","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib8","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","article-title":"The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis","volume":"73","author":"Cottrell","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/03009742.2017.1299793","article-title":"There is a need for new systemic sclerosis subset criteria. A content analytic approach","volume":"47","author":"Johnson","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/RHU.0b013e31820e7e8d","article-title":"Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires","volume":"17","author":"Rosa","year":"2011","journal-title":"J\u00a0Clin Rheumatol Pract Rep Rheum & Musculoskel Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3899\/jrheum.111106","article-title":"Epidemiology of systemic sclerosis in a large US managed care population","volume":"39","author":"Furst","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.reuma.2014.01.011","article-title":"Scleroderma in the Caribbean: characteristics in a Dominican case series","volume":"10","author":"Gottschalk","year":"2014","journal-title":"Reumatol Cl\u00ednica"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rbr.2016.05.008","article-title":"Incidence and prevalence of systemic sclerosis in Campo Grande, state of mato Grosso do Sul, Brazil","volume":"57","author":"Horimoto","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.berh.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-11-98","article-title":"The prevalence of rheumatic diseases in central Greece: a population survey","volume":"11","author":"Anagnostopoulos","year":"2010","journal-title":"BMC Muscoskel Disord"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10067-009-1341-6","article-title":"Prevalence of systemic sclerosis in Split-Dalmatia county in Southern Croatia","volume":"29","author":"Radic","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2018.08.005_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/rheumatology\/kes076","article-title":"Prevalence of systemic sclerosis in south-east Norway","volume":"51","author":"Hoffmann-Vold","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5455\/msm.2013.25.14-18","article-title":"Incidence, prevalence and clinical manifestations of systemic sclerosis in dukagjini plain","volume":"25","author":"Bajraktari","year":"2013","journal-title":"Mater Soc Med"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.semarthrit.2012.10.001","article-title":"Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method","volume":"42","author":"El Adssi","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"2 Suppl 65","key":"10.1016\/j.berh.2018.08.005_bib21","first-page":"S10","article-title":"Epidemiology of systemic sclerosis in a district of northern Italy","volume":"29","author":"Lo Monaco","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.berh.2018.08.005_bib22","first-page":"8","article-title":"Incidence of scleroderma spectrum disorders in Slovenia","volume":"31","author":"Sipek Dolnicar","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2018.08.005_bib23","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2013-203618","article-title":"Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria","volume":"73","author":"Andreasson","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib24","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/art.39613","article-title":"Brief report: spatial heterogeneity of systemic sclerosis in France: high prevalence in the northeast region","volume":"68","author":"Meyer","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5604\/12321966.1233570","article-title":"Incidence and prevalence of Systemic Sclerosis (SSc) in Poland - differences between rural and urban regions","volume":"24","author":"Kanecki","year":"2017","journal-title":"Ann Agric Environ Med AAEM"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/03009742.2011.553736","article-title":"Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan","volume":"40","author":"Kuo","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/acr.21820","article-title":"Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan","volume":"65","author":"Yu","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib28","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/bjd.15838","article-title":"Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study","volume":"178","author":"Kang","year":"2018","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.berh.2018.08.005_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2796.1996.14843000.x","article-title":"Incidence of rare systemic rheumatic and connective tissue diseases in Finland","volume":"240","author":"Kaipiainen-Seppanen","year":"1996","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.berh.2018.08.005_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2018.08.005_bib34","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","article-title":"Digital ulcers predict a worse disease course in patients with systemic sclerosis","volume":"75","author":"Mihai","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2018.08.005_bib36","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib37","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/annrheumdis-2015-207271","article-title":"Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database","volume":"75","author":"Wirz","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib40","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2018.08.005_bib41","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/annrheumdis-2014-205295","article-title":"Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Avouac","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2018.08.005_bib43","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the university of California, Los Angeles scleroderma clinical trial Consortium gastrointestinal tract instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5301\/jsrd.5000214","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"1","author":"Shreiner","year":"2016","journal-title":"J\u00a0Scleroderma Relat Dis"},{"issue":"137","key":"10.1016\/j.berh.2018.08.005_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/16000617.00002915","article-title":"Interstitial lung disease in systemic sclerosis: where do we stand?","volume":"24","author":"Cappelli","year":"2015","journal-title":"Eur Respir Rev \u2013 Offic J Eur Respir Soc"},{"issue":"6","key":"10.1016\/j.berh.2018.08.005_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/BOR.0000000000000323","article-title":"Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis","volume":"28","author":"Molberg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2018.08.005_bib47","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2018.08.005_bib48","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.berh.2018.08.005_bib49","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib50","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"126","key":"10.1016\/j.berh.2018.08.005_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1183\/09059180.00005412","article-title":"Challenges in the diagnosis and treatment of pulmonary arterial hypertension","volume":"21","author":"Vachiery","year":"2012","journal-title":"Eur Respir Rev \u2013 Offic J Eur Respir Soc"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/ken488","article-title":"Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study","volume":"48","author":"Hachulla","year":"2009","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2018.08.005_bib55","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/annrheumdis-2017-211480","article-title":"Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort","volume":"77","author":"Mihai","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.005_bib57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2397198317747441","article-title":"Update on assessment and management of primary cardiac involvement in systemic sclerosis","volume":"3","author":"Bournia","year":"2018","journal-title":"J\u00a0Scleroderma Rel Dis"},{"issue":"12","key":"10.1016\/j.berh.2018.08.005_bib58","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2018.08.005_bib59","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib60","first-page":"485","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM Mon J Assoc Phys"},{"key":"10.1016\/j.berh.2018.08.005_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: from pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J\u00a0Scleroderma Rel Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","article-title":"Corticosteroids and the risk of scleroderma renal crisis: a systematic review","volume":"32","author":"Trang","year":"2012","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib63","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib65","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/annrheumdis-2018-212999","article-title":"Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer","volume":"77","author":"Igusa","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6167","key":"10.1016\/j.berh.2018.08.005_bib67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology"},{"issue":"Suppl_5","key":"10.1016\/j.berh.2018.08.005_bib69","doi-asserted-by":"crossref","first-page":"v23","DOI":"10.1093\/rheumatology\/kex194","article-title":"Points to consider for designing trials in systemic sclerosis patients with arthritic involvement","volume":"56","author":"Clements","year":"2017","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2018.08.005_bib70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","article-title":"The clinical relevance of sexual dysfunction in systemic sclerosis","volume":"14","author":"Bruni","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2018.08.005_bib71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/1756-0500-7-594","article-title":"Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses","volume":"7","author":"Bretterklieber","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.berh.2018.08.005_bib72","doi-asserted-by":"crossref","first-page":"507493","DOI":"10.1155\/2013\/507493","article-title":"In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors","volume":"2013","author":"Del Rosso","year":"2013","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090484","article-title":"Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-014-0484-x","article-title":"Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance","volume":"17","author":"Korman","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib75","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","article-title":"Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis","volume":"35","author":"Arora-Singh","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib78","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2018.08.005_bib79","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00439-011-1137-z","article-title":"Unraveling the genetic component of systemic sclerosis","volume":"131","author":"Martin","year":"2012","journal-title":"Hum Genet"},{"issue":"19","key":"10.1016\/j.berh.2018.08.005_bib80","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","article-title":"A\u00a0systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci","volume":"22","author":"Martin","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.berh.2018.08.005_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874312901408010029","article-title":"Systemic sclerosis is a complex disease associated mainly with immune regulatory and inflammatory genes","volume":"8","author":"Jin","year":"2014","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.berh.2018.08.005_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-kappaB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2018.08.005_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib84","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib85","first-page":"89","article-title":"Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review","volume":"106","author":"Freire","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib86","first-page":"177","article-title":"Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes","volume":"1","author":"Peoples","year":"2016","journal-title":"J\u00a0Scleroderma Relat Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib87","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.berh.2018.08.005_bib89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2018.08.005_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.04.002","article-title":"Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: a review","volume":"318","author":"Zhang","year":"2017","journal-title":"Cell Immunol"},{"issue":"11","key":"10.1016\/j.berh.2018.08.005_bib91","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM200003163421105","article-title":"Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases","volume":"342","author":"Janowsky","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.berh.2018.08.005_bib92","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semarthrit.2016.07.010","article-title":"Measures of disease status in systemic sclerosis: a systematic review","volume":"46","author":"Tay","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib93","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/annrheumdis-2014-206485","article-title":"The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments","volume":"74","author":"Castrejon","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2018.08.005_bib94","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.semarthrit.2016.10.002","article-title":"Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: an evolutional database model of validated patient-reported outcomes","volume":"46","author":"Ingegnoli","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2397198318765061","article-title":"The challenges and controversies of measuring disease activity in systemic sclerosis","volume":"3","author":"Ross","year":"2018","journal-title":"J\u00a0Scleroderma Relat Dis"},{"issue":"2","key":"10.1016\/j.berh.2018.08.005_bib96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.rdc.2016.01.003","article-title":"Patient-reported outcome measures in systemic sclerosis (scleroderma)","volume":"42","author":"Pellar","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"issue":"10","key":"10.1016\/j.berh.2018.08.005_bib97","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3899\/jrheum.090372","article-title":"Measures of response in clinical trials of systemic sclerosis: the combined response index for systemic sclerosis (CRISS) and outcome measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS)","volume":"36","author":"Khanna","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"15","key":"10.1016\/j.berh.2018.08.005_bib98","first-page":"147","article-title":"The EULAR systemic sclerosis impact of disease (SCLEROID) score \u2013 a new patient-reported outcome measure for patients with systemic sclerosis - preliminary results from the ongoing validation study","volume":"3","author":"Dobrota","year":"2018","journal-title":"J\u00a0Scleroderma Relat Dis"},{"issue":"8","key":"10.1016\/j.berh.2018.08.005_bib99","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3899\/jrheum.090504","article-title":"The symptom burden index: development and initial findings from use with patients with systemic sclerosis","volume":"37","author":"Kallen","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl_5","key":"10.1016\/j.berh.2018.08.005_bib100","doi-asserted-by":"crossref","first-page":"v17","DOI":"10.1093\/rheumatology\/kex193","article-title":"Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis","volume":"56","author":"Khanna","year":"2017","journal-title":"Rheumatology"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:17:24Z","timestamp":1761499044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694218300421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1521694218300421"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}